Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1996 4
1997 1
1999 2
2000 1
2001 3
2002 5
2003 3
2004 2
2005 10
2006 7
2007 12
2008 3
2009 6
2010 6
2011 7
2012 10
2013 12
2014 7
2015 9
2016 5
2017 4
2018 5
2019 6
2020 11
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Results by year
Filters applied: . Clear all
Page 1
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.
Biolato M, Bianco A, Lucchini M, Gasbarrini A, Mirabella M, Grieco A. Biolato M, et al. CNS Drugs. 2021 Aug;35(8):861-880. doi: 10.1007/s40263-021-00842-9. Epub 2021 Jul 28. CNS Drugs. 2021. PMID: 34319570 Free PMC article. Review.
Patients with multiple sclerosis should be informed about possible hepatic side effects of their treatment. ...Beta interferon, glatiramer acetate, natalizumab, and alemtuzumab are relatively contraindicated in autoimmune hepatitis due to the risk of disease …
Patients with multiple sclerosis should be informed about possible hepatic side effects of their treatment. ...Beta interferon …
Hepatitis C during disease modifying therapy with Fingolimod for Relapsing Remitting Multiple Sclerosis: diagnosis and treatment.
Aslanyan A, Anwar-Hashim Z, Siripurapu R, Mihalova T. Aslanyan A, et al. BMJ Case Rep. 2021 Feb 26;14(2):e238167. doi: 10.1136/bcr-2020-238167. BMJ Case Rep. 2021. PMID: 33637491
Unexpectedly after 2.5 years of stable MS symptoms and liver function tests (LFTs), we noted deranged LFTs during routine testing. Additional investigations showed hepatitis C positivity, genotype 3. It is likely a case of hepatitis C reactivation seco …
Unexpectedly after 2.5 years of stable MS symptoms and liver function tests (LFTs), we noted deranged LFTs during routine testing. Additiona …
Interferon Beta: From Molecular Level to Therapeutic Effects.
Haji Abdolvahab M, Mofrad MR, Schellekens H. Haji Abdolvahab M, et al. Int Rev Cell Mol Biol. 2016;326:343-72. doi: 10.1016/bs.ircmb.2016.06.001. Epub 2016 Jul 20. Int Rev Cell Mol Biol. 2016. PMID: 27572132 Review.
The biological activities underpin the mechanisms by which the protein is used to treat various diseases such as hepatitis C infection and multiple sclerosis. Despite the success of IFNbeta therapy, the drug may evoke the production of antidrug antibod …
The biological activities underpin the mechanisms by which the protein is used to treat various diseases such as hepatitis C i …
Prospects for the Use of Cannabinoids in Psychiatric Disorders.
Graczyk M, Łukowicz M, Dzierzanowski T. Graczyk M, et al. Front Psychiatry. 2021 Mar 12;12:620073. doi: 10.3389/fpsyt.2021.620073. eCollection 2021. Front Psychiatry. 2021. PMID: 33776815 Free PMC article. Review.
In a small number of clinical trials, cannabinoids used to treat cancer, HIV, multiple sclerosis, hepatitis C, Crohn's disease, and chronic neuropathic pain report decreases in anxiety or depression symptoms and presented sedative and anxiolytic effect …
In a small number of clinical trials, cannabinoids used to treat cancer, HIV, multiple sclerosis, hepatitis C, C …
Alemtuzumab.
[No authors listed] [No authors listed] 2020 Apr 14. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Apr 14. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643537 Free Books & Documents. Review.
Alemtuzumab is a recombinant human monoclonal antibody to human CD52 which is used in the therapy of chronic lymphocytic leukemia, in induction regimens for solid organ transplantation and for resistant forms of relapsing multiple sclerosis. Alemtuzumab has not been …
Alemtuzumab is a recombinant human monoclonal antibody to human CD52 which is used in the therapy of chronic lymphocytic leukemia, in induct …
Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.
Söderholm J, Yilmaz A, Svenningsson A, Büsch K, Wejstål R, Brolund A, Kövamees J, Sällberg M, Lagging M, Gisslén M. Söderholm J, et al. J Neurol. 2019 Sep;266(9):2208-2215. doi: 10.1007/s00415-019-09397-8. Epub 2019 May 31. J Neurol. 2019. PMID: 31152298 Free PMC article.
BACKGROUND: Multiple sclerosis (MS) is an immune-mediated neurological disease that causes demyelination. ...In contrast, people living with HIV have a lower risk of developing MS. Hepatitis C virus (HCV) mainly infects the liver, but patients with HCV …
BACKGROUND: Multiple sclerosis (MS) is an immune-mediated neurological disease that causes demyelination. ...In contrast, peop …
Interferon.
Khanna NR, Gerriets V. Khanna NR, et al. 2021 Jul 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2021 Jul 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32310392 Free Books & Documents.
Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin's lymphoma, and autoimmune diseases such as multiple sclerosis. ...
Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin's lymph …
Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.
Gupta M, Yamauchi PS, Bagot M, Szepietowski J, Bhatia S, Lotti T, Goldust M. Gupta M, et al. Clin Case Rep. 2020 May 26;8(9):1647-1650. doi: 10.1002/ccr3.2971. eCollection 2020 Sep. Clin Case Rep. 2020. PMID: 32983469 Free PMC article.
Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea....
Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used …
Multiple Sclerosis Like Condition in a Patient of Hepatitis C after Treatment with Interferon Alpha: A Case Report.
Fazil PA, Ali SM, Zaboli M, Shah SR. Fazil PA, et al. J Clin Diagn Res. 2015 May;9(5):OD14-5. doi: 10.7860/JCDR/2015/12588.5962. Epub 2015 May 1. J Clin Diagn Res. 2015. PMID: 26155513 Free PMC article.
Hepatitis C virus affects millions of people around the world. The primary therapy comprises of interferon alpha and ribavarin. ...Our case report presents a 35-year-old man who was a known case of Hepatitis C presenting to us with altered level of con
Hepatitis C virus affects millions of people around the world. The primary therapy comprises of interferon alpha and ribavarin
140 results